ALL YOU NEED TO KNOW ABOUT NRX PHARMACEUTICALS!
Post# of 44
$NRXP
There is a lot of buzz around NRx Pharmaceuticals, Inc. (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, developing ZYESAMI™ (AVIPTADIL®) for the treatment of respiratory failure in critical COVID-19 patients.
The Company has recently submitted a revised Investigational New Drug (IND) module for ZYESAMI, which was met with much cheer by the investors. However, RELIEF THERAPEUTICS Holding AG has filed a lawsuit against the Company, claiming failure to honor its obligations under the collaboration agreement entered between the companies in September 2020.
Read on to find out more
https://www.aviseanalytics.com/all-you-need-t...ceuticals/